Sign for Notice Everyday    Sign Up| Sign In| Link|

Our Sponsors

    Receive Latest News

    Share Us

    CTTM 2021 - The International Conference on Cancer Therapy and Translational Medicine (CTTM 2021)

    View: 780

    Website | Edit Freely

    Category Cancer Therapy; Translational Medicine

    Deadline: November 26, 2021 | Date: November 28, 2021-November 30, 2021

    Venue/Country: Xiamen, China

    Updated: 2020-11-27 18:04:17 (GMT+9)

    Call For Papers - CFP

    The International Conference on Cancer Therapy and Translational Medicine (CTTM 2021)

    Conference Date: November 26-28, 2021

    Conference Venue: Xiamen, China


    Online Registration System:


    The International Conference on Cancer Therapy and Translational Medicine (CTTM 2021) will be held during November 26-28, 2021 in Xiamen, China. This Conference will cover issues on Cancer and Biopsies, Cancer Diagnostics Tools, Technologies and Procedures, Clinical Cancer research, Clinical Management of Cancer, Translational medicine, Viral Oncology and other Related Topics. It dedicates to creating a stage for exchanging the latest research results and sharing the advanced research methods.

    If you wish to serve the conference as an invited speaker, please send email to us with your CV. We'll contact with you asap.

    Publication and Presentation

    Publication: Open Access Journal´╝îplease contact us for detailed information

    Index: CNKI and Google Scholar

    Note: If you want to present your research results but do NOT wish to publish a paper, you may simply submit an Abstract to our Registration System.

    Contact Us


    Tel: +86 13264702250

    QQ: 1349406763, 3025797047

    WeChat: 3025797047

    Twitter: conf_Committee

    Attendance Methods

    1.Submit full paper (Regular Attendance+Paper Publication+Presentation)

    You are welcome to submit full paper, all the accepted papers will be published by Open access journal.

    2. Submit abstract (Regular Attendance+Abstract+Presentation)

    3. Regular Attendance (No Submission Required)

    Conference Topics

    Advances in Translational Medicine

    Alternative Medicine in Cancer Research

    Big Data Analysis in Cancer Therapeutics

    Biomarkers in Translational Medicine

    Cancer & Biopsies

    Cancer Biobank

    Cancer Biology and Cancer Bioinformatics

    Cancer Diagnostics Tools, Technologies and Procedures

    Cancer Driver Gene Detection

    Cancer Epidemiology

    Cancer Evolution

    Cancer Genomics and Epigenetics

    Cancer Heterogeneity

    Cancer Imaging

    Cancer Immunotherapy

    Cancer Medical Research

    Cancer Metastasis

    Cancer Nanotechnology

    Cancer Pharmacology

    Cancer Screening and Diagnosis

    Cancer Vaccines and Therapeutics


    Chemotherapy and Oncology Nursing

    Clinical and Translational Oncology

    Clinical Cancer research

    Clinical Management of Cancer

    Comprehensive Prevention & Control of Cancer

    Drug Discovery & Development

    Early diagnostics and imagery

    Interventional radiology

    Molecular Targeted Therapy

    New biomarkers

    Novel Cancer Drugs and its Pharmacology

    Oncogene Sequencing

    Organ Specific cancer

    Precision Cancer Medicine

    Precision Medicine

    Predictive Cancer Biomarkers

    Proton and Heavy-Ion Therapies of Cancer

    Radiation Therapy

    Stem Cell Therapy

    Targeted Cancer Therapies

    Translational and Interventional Oncology

    Translational Cardiology and Vascular Medicine

    Translational medicine

    Translational Modeling of Efficacy and Safety

    Translational of Animal Models to Clinic

    Translational Research in Blood Disorders

    Translational Therapeutics and Technologies

    Tumor Microenvironment

    Viral Oncology

    Other Related Topics

    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.